vs
iSpecimen Inc.（ISPC）与NATIONAL RESEARCH CORP（NRC）财务数据对比。点击上方公司名可切换其他公司
NATIONAL RESEARCH CORP的季度营收约是iSpecimen Inc.的679.9倍（$35.2M vs $51.8K）。NATIONAL RESEARCH CORP净利率更高（5.1% vs -9662.2%，领先9667.3%）。NATIONAL RESEARCH CORP同比增速更快（-4.6% vs -96.5%）。过去两年NATIONAL RESEARCH CORP的营收复合增速更高（-0.2% vs -85.0%）
Specimen Products是一家总部位于芝加哥的乐器与音响设备制造商，由制琴师伊恩·施纳勒创立，主打定制吉他、电子管功放与号角音箱产品。品牌还依托旗下芝加哥吉他制作学院开设吉他、电子管功放的设计、制作与维修课程，工坊也面向公众提供设备维修服务，可调用稀有 vintage 厂商的零件储备开展维修。
NRC Health（原国家研究公司）是一家美国医疗健康企业，1981年成立，总部位于内布拉斯加州林肯市。公司主要在美加两国提供医疗健康相关产品及订阅式解决方案，深耕区域医疗健康服务领域。
ISPC vs NRC — 直观对比
营收规模更大
NRC
是对方的679.9倍
$51.8K
营收增速更快
NRC
高出91.8%
-96.5%
净利率更高
NRC
高出9667.3%
-9662.2%
两年增速更快
NRC
近两年复合增速
-85.0%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $51.8K | $35.2M |
| 净利润 | $-5.0M | $1.8M |
| 毛利率 | -964.4% | — |
| 营业利润率 | -5192.9% | 13.3% |
| 净利率 | -9662.2% | 5.1% |
| 营收同比 | -96.5% | -4.6% |
| 净利润同比 | 17.3% | -72.6% |
| 每股收益（稀释后） | $-0.67 | $49.58 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ISPCNRC
| Q4 25 | $51.8K | $35.2M | ||
| Q3 25 | $106.6K | $34.6M | ||
| Q2 25 | $713.1K | $34.0M | ||
| Q1 25 | $1.1M | $33.6M | ||
| Q4 24 | $1.5M | $36.9M | ||
| Q3 24 | $2.7M | $35.8M | ||
| Q2 24 | $2.9M | $35.0M | ||
| Q1 24 | $2.3M | $35.3M |
净利润ISPCNRC
| Q4 25 | $-5.0M | $1.8M | ||
| Q3 25 | $-2.8M | $4.1M | ||
| Q2 25 | $-1.0M | $-106.0K | ||
| Q1 25 | $-1.7M | $5.8M | ||
| Q4 24 | $-6.0M | $6.6M | ||
| Q3 24 | $-1.4M | $5.7M | ||
| Q2 24 | $-2.1M | $6.2M | ||
| Q1 24 | $-2.9M | $6.4M |
毛利率ISPCNRC
| Q4 25 | -964.4% | — | ||
| Q3 25 | -47.0% | — | ||
| Q2 25 | 44.4% | — | ||
| Q1 25 | 42.4% | — | ||
| Q4 24 | 13.5% | — | ||
| Q3 24 | 43.4% | — | ||
| Q2 24 | 51.9% | — | ||
| Q1 24 | 58.4% | — |
营业利润率ISPCNRC
| Q4 25 | -5192.9% | 13.3% | ||
| Q3 25 | -2655.2% | 22.4% | ||
| Q2 25 | -255.4% | 4.7% | ||
| Q1 25 | -154.9% | 25.6% | ||
| Q4 24 | -395.8% | 26.0% | ||
| Q3 24 | -64.1% | 22.3% | ||
| Q2 24 | -76.2% | 25.3% | ||
| Q1 24 | -131.0% | 24.8% |
净利率ISPCNRC
| Q4 25 | -9662.2% | 5.1% | ||
| Q3 25 | -2608.7% | 11.9% | ||
| Q2 25 | -146.9% | -0.3% | ||
| Q1 25 | -156.8% | 17.2% | ||
| Q4 24 | -409.8% | 17.8% | ||
| Q3 24 | -54.1% | 15.9% | ||
| Q2 24 | -73.6% | 17.6% | ||
| Q1 24 | -126.7% | 18.0% |
每股收益（稀释后）ISPCNRC
| Q4 25 | $-0.67 | $49.58 | ||
| Q3 25 | $-0.48 | $0.18 | ||
| Q2 25 | $-0.42 | $-0.01 | ||
| Q1 25 | $-0.71 | $0.25 | ||
| Q4 24 | $-5.40 | $0.27 | ||
| Q3 24 | $-2.10 | $0.24 | ||
| Q2 24 | $-3.72 | $0.26 | ||
| Q1 24 | $-6.36 | $0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $6.9M | $4.1M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $3.1M | $14.0M |
| 总资产 | $9.5M | $134.9M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ISPCNRC
| Q4 25 | $6.9M | $4.1M | ||
| Q3 25 | — | $2.2M | ||
| Q2 25 | — | $5.3M | ||
| Q1 25 | — | $2.5M | ||
| Q4 24 | $1.9M | $4.2M | ||
| Q3 24 | $1.8M | $3.5M | ||
| Q2 24 | $2.2M | $485.0K | ||
| Q1 24 | $2.1M | $1.7M |
总债务ISPCNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $48.7M | ||
| Q2 24 | — | $33.3M | ||
| Q1 24 | — | $35.2M |
股东权益ISPCNRC
| Q4 25 | $3.1M | $14.0M | ||
| Q3 25 | $3.1M | $14.3M | ||
| Q2 25 | $622.0K | $21.3M | ||
| Q1 25 | $1.7M | $29.7M | ||
| Q4 24 | $3.3M | $31.3M | ||
| Q3 24 | $4.7M | $34.6M | ||
| Q2 24 | $6.1M | $40.2M | ||
| Q1 24 | $6.8M | $36.9M |
总资产ISPCNRC
| Q4 25 | $9.5M | $134.9M | ||
| Q3 25 | $9.0M | $135.7M | ||
| Q2 25 | $6.0M | $141.4M | ||
| Q1 25 | $6.8M | $135.2M | ||
| Q4 24 | $9.4M | $132.5M | ||
| Q3 24 | $11.3M | $131.8M | ||
| Q2 24 | $11.9M | $119.1M | ||
| Q1 24 | $12.5M | $120.9M |
负债/权益比ISPCNRC
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 1.41× | ||
| Q2 24 | — | 0.83× | ||
| Q1 24 | — | 0.95× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-916.9K | $7.2M |
| 自由现金流经营现金流 - 资本支出 | — | $6.1M |
| 自由现金流率自由现金流/营收 | — | 17.2% |
| 资本支出强度资本支出/营收 | — | 3.2% |
| 现金转化率经营现金流/净利润 | — | 3.99× |
| 过去12个月自由现金流最近4个季度 | — | $15.7M |
8季度趋势，按日历期对齐
经营现金流ISPCNRC
| Q4 25 | $-916.9K | $7.2M | ||
| Q3 25 | $-2.0M | $13.8M | ||
| Q2 25 | $-192.2K | $-1.1M | ||
| Q1 25 | $-1.1M | $6.6M | ||
| Q4 24 | $-3.6M | $6.4M | ||
| Q3 24 | $-1.1M | $9.4M | ||
| Q2 24 | $-1.5M | $6.8M | ||
| Q1 24 | $-2.1M | $12.0M |
自由现金流ISPCNRC
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $10.2M | ||
| Q2 25 | — | $-4.1M | ||
| Q1 25 | — | $3.7M | ||
| Q4 24 | $-3.6M | $1.9M | ||
| Q3 24 | $-1.1M | $7.8M | ||
| Q2 24 | — | $1.5M | ||
| Q1 24 | $-2.1M | $7.9M |
自由现金流率ISPCNRC
| Q4 25 | — | 17.2% | ||
| Q3 25 | — | 29.4% | ||
| Q2 25 | — | -12.2% | ||
| Q1 25 | — | 10.9% | ||
| Q4 24 | -242.7% | 5.2% | ||
| Q3 24 | -41.1% | 21.8% | ||
| Q2 24 | — | 4.3% | ||
| Q1 24 | -90.9% | 22.4% |
资本支出强度ISPCNRC
| Q4 25 | — | 3.2% | ||
| Q3 25 | 0.0% | 10.4% | ||
| Q2 25 | — | 8.8% | ||
| Q1 25 | — | 8.9% | ||
| Q4 24 | 0.5% | 12.0% | ||
| Q3 24 | 0.5% | 4.5% | ||
| Q2 24 | 0.0% | 15.0% | ||
| Q1 24 | 0.4% | 11.7% |
现金转化率ISPCNRC
| Q4 25 | — | 3.99× | ||
| Q3 25 | — | 3.34× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 0.97× | ||
| Q3 24 | — | 1.66× | ||
| Q2 24 | — | 1.10× | ||
| Q1 24 | — | 1.89× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
